Wayne Shiong

Established in 2018, InxMed strives to be a China-based global new drug development engine dedicated to the development of innovative drugs with high probability of success and meaningful value for patients globally by execution of our “Best-in-Disease Combination” strategy and leveraging China clinical resources. In InxMed, we think differently, because we know the deep understanding of disease biology and value-driven study design are how we differentiate from others. In InxMed, we value the highest efficiency in execution and expeditious generation of “PoC” data, because we know “Vision without execution is hallucination”. In InxMed, we believe combination therapy is the future for oncology, and triple or multiple drug combinations are emerging with great potential. In InxMed, we strive to build up a pipeline consisting of “First-in-Class” and “Best-in-Disease Combination” assets, driven by intrinsic potential of synergy.

Startup company, currently in stealth mode.

Singleron Biotechnologies is an innovative molecular diagnostic company dedicated to applying groundbreaking high-throughput single cell analyses to clinical research, diagnostics and drug development. 500+ single-cell sequencing experts around the world are working together to translate advanced and proprietary multi-omics single-cell technologies into products that can be easily deployed in any lab and provide improved research results faster than ever before. The company was incorporated in January 2018 and currently has offices and laboratories in China, US, and Germany. Contact: info@singleronbio.com

4B Technologies was founded with its mission to focus on novel medicines for neurodegenerative diseases and neurological injuries. With deep insights in neurosciences and CNS drug discovery, we have developed a strategic framework to increase probability of success by tackling key challenges faced in CNS drug research and development, including targeting strategy, animal model development, basic-to-clinical translation, biomarkers, and clinical trial design. Through in-house drug discovery efforts as well as strategic alliance with academic and industrial partners, 4B Technologies has built and is advancing a pipeline of innovative medicines into the clinic to validate their therapeutic potentials. Our aspiration is to become a global leader in developing innovative medicines for neurological diseases. 4B Technologies was registered in Cayman and Hong Kong in 2017 and began its full operation in 2018 with preclinical R&D in Suzhou, and later clinical development in Beijing and Shanghai, China.

Land Space Technology Co. Ltd. (referred to as hereinafter "LandSpace"​) was founded in June 2015 with focus on the design, manufacturing and operations of small and medium launch vehicles. LandSpace is devoted to the development of Liquid-fuel ( LOX+LCH4）Rocket Engines (LREs) and low-cost commercial launch vehicles with independent intellectual property rights. LandSpace could complete the system and unit design, manufacture, test and delivery with highly-integrated design and innovation capability by a first-class technical team, to provide economical and reliable high-quality launch services for commercial satellites and special-purpose spacecrafts, as well as development of new technologies and systems for space applications.

On a mission to develop the next generation user interface, Nreal has been at the forefront of actively developing consumer-facing mixed reality wearables since 2017. Its flagship product Nreal Light is a pair of light weight and comfortable-to-wear mixed reality glasses that sport an industry-leading wide-screen and vivid display. Beginning with Nreal Light’s debut in early 2019, Nreal has stood out with accolades including “Best Start-up” at CES and “Best in Show” at the Augmented World Expo (AWE). By collaborating with world-class partners that share Nreal’s vision, Nreal is devoted to making mixed reality available and readily accessible to all.

DeePhi Tech, a Xilinx company, provides end-to-end solutions utilizing deep compression technology and deep-learning processor unit (DPU) platforms.

ScaleFlux - the enterprise Flash Storage and Memory innovators. Unlock unprecedented performance, efficiency, security, and scalability for your data infrastructure – from AI/ML, enterprise, and data center to edge computing and inferencing.

WeRide is a global leading company that develops Level 4 autonomous driving technologies, bringing smart cities with new products, new business model and new experience. WeRide has received strategic investments from top-tier global automakers, including Renault-Nissan-Mitsubishi Alliance and Yutong Group. WeRide is the first startup in the world that holds driverless test permits in both China and the US. Through strategic alliances with car makers, mobility and logistics service platforms, WeRide offers an all-rounded product mix of Robotaxi, Mini Robobus and Robovan to provide multiple services including online ride-hailing, on-demand transport and urban logistics. WeRide launched China’s first Robotaxi service, completely open to public, in November 2019, in Guangzhou, China, covering an area of 144 square kilometers. WeRide has also conducted commercial pilot operations and fully driverless testing for Mini Robobus and Robovan. Established in 2017, WeRide is headquartered in Guangzhou, China, and maintains R&D and operation centers in Beijing, Shanghai, Shenzhen, Nanjing, Wuhan, Zhengzhou and Anqing, as well as San Jose in the US. It employs a highly skilled team of over 800 employees around the globe and has extensive domestic and international experience in R&D, business development and operations.

PlusAI is an artificial intelligence company pioneering AI-based virtual driver software for factory-built autonomous trucks. Headquartered in Silicon Valley with operations in the United States and Europe, PlusAI was named by Fast Company as one of the World’s Most Innovative Companies. Partners including TRATON GROUP’s Scania, MAN, and International brands, Hyundai Motor Company, Iveco Group, Bosch, and DSV are working with PlusAI to accelerate the deployment of next-generation autonomous trucks. PlusAI announced in June 2025 that it plans to go public via a merger with Churchill Capital Corp IX (NASDAQ: CCIX).

Seyond™ is a leading global provider of image-grade LiDAR technology, powering a safer, smarter and more mobile world across the automotive, intelligent transportation, robotics and industrial automation sectors. Founded in Silicon Valley with strategically placed research and manufacturing facilities across the globe, Seyond is crafting LiDAR solutions that elevate autonomous driving and fuel the advancement of smart infrastructure development. The company’s dynamic portfolio – including ultra-long range flagship LiDAR sensor Falcon, mid-to-short range LiDAR sensor Robin and perception service software platform OmniVidi – powers automotive and ITS solutions for partners like NIO, Faraday Future, Exwayz and Hexagon. Currently, over 200,000 Falcon units are in use, and the product continues to be mass-produced today. See Smarter™.

Tezign has the vision Technology Empowers Imagination. Founded in 2015, Tezign aims to build the digital infrastructure of content experience. Tezign provides digital platform based on enterprise content workflow, connecting content production, management and application, to help brands drive growth with content. Tezign has partnered with more than 200 medium to large enterprises such as Alibaba, Unilever, ByteDance, Pepsi, Shiseido, P&G, Heinz, Coca Cola, Budweiser, ant financial, Nestle, Tencent, LOreal, Danone, China Ping An, CICC, Porsche, Audi, Aptar, etc to build content platforms and upgrade their content strategies. It has produced more than 150,000 content assets and formed a ten million level content asset management scale. Tezigns content ecosystem has gathered more than 50,000 content creators. Tezign has raised the D1 round of financing and become the only Contech unicorn enterprise with a valuation of more than US $1 billion. Tezign is backed by world recognized investors including Temasek, Sequoia Capital, Hearst Ventures, Linear Capital, among others. Tezign, as a leading pioneer of design and artificial intelligence in China, has obtained 20 + invention patents and 30 + copyrights of design intelligence related software. In 2017, Tezign and Tongji University jointly founded Design A.I. Laboratory and graduate program for applied research to bring machine learning and A.I. technology to content creation and experience design. Tezign was a National Industrial Design Center issued by the Ministry of industry and information technology, awarded as TOP.1 in China in the list of The Information 50 startups, Fast Company top 50 of Chinas best innovative companies, Forbes High Growth Gazelle, Forbes China Top 10 intelligent design enterprises, Hurun Group Lisf of Global Unicorn, and was named by Forrester "Now Tech: Marketing Resource Management, Q12022" (MRM) as the only MRM vendor in the contech segment Asia Pacific.

How did you discover things you'd never heard of? Ever dazzled by endless selections in a bookstore or a web store? There're millions of new books, movies and music albums released each year. There got to be dozens in these that suit you perfectly, but you'll probably miss many of them. Best seller lists tell you the popular ones, but what about the rest? The creators of Douban find tips from friends and colleagues most helpful. A casual mention or two passes on their own judgments on things, and their knowledge of you. A friend won't recommend nursing books to a bachelor, or bring home "Naked Killer" to grandma. Sadly, put all of the friends and families of you and me together, what they've known are still hopelessly limited. Plus, people of most similar tastes are often strangers to each other. If only there's a way to know tastes of millions of people, and point out the ones most like yourself. The power of words-of-mouth would be amplified many times over. Douban was created out of this very wish. It does not target to any particular group of people. No matter how bizarre or commonly the things you like, Douban helps to you find the people who shares these interests, and discover more good stuff through them.

MOGU.Inc (NYSE-listed) is a fashion and lifestyle platform based in China that uses AI technology to connect fashion influencers, brands, and consumers. The company was founded in 2011 and has since grown to become one of the largest fashion e-commerce platforms in China. MOGU.Inc is at the forefront of using AI and machine learning to enhance the shopping experience.

Bertelsmann is a media, services, and education company with more than 75,000 employees that operates in some 50 countries around the world. It includes the entertainment group RTL Group, the trade book publisher Penguin Random House, the music company BMG, the service provider Arvato Group, Bertelsmann Marketing Services, the Bertelsmann Education Group, and Bertelsmann Investments. The company generated revenues of €19 billion in the 2025 financial year. Bertelsmann stands for creativity and entrepreneurship. This combination promotes first-class media content and innovative service solutions that inspire customers around the world. www.bertelsmann.com

Established in 2018, InxMed strives to be a China-based global new drug development engine dedicated to the development of innovative drugs with high probability of success and meaningful value for patients globally by execution of our “Best-in-Disease Combination” strategy and leveraging China clinical resources. In InxMed, we think differently, because we know the deep understanding of disease biology and value-driven study design are how we differentiate from others. In InxMed, we value the highest efficiency in execution and expeditious generation of “PoC” data, because we know “Vision without execution is hallucination”. In InxMed, we believe combination therapy is the future for oncology, and triple or multiple drug combinations are emerging with great potential. In InxMed, we strive to build up a pipeline consisting of “First-in-Class” and “Best-in-Disease Combination” assets, driven by intrinsic potential of synergy.

Startup company, currently in stealth mode.

Singleron Biotechnologies is an innovative molecular diagnostic company dedicated to applying groundbreaking high-throughput single cell analyses to clinical research, diagnostics and drug development. 500+ single-cell sequencing experts around the world are working together to translate advanced and proprietary multi-omics single-cell technologies into products that can be easily deployed in any lab and provide improved research results faster than ever before. The company was incorporated in January 2018 and currently has offices and laboratories in China, US, and Germany. Contact: info@singleronbio.com

4B Technologies was founded with its mission to focus on novel medicines for neurodegenerative diseases and neurological injuries. With deep insights in neurosciences and CNS drug discovery, we have developed a strategic framework to increase probability of success by tackling key challenges faced in CNS drug research and development, including targeting strategy, animal model development, basic-to-clinical translation, biomarkers, and clinical trial design. Through in-house drug discovery efforts as well as strategic alliance with academic and industrial partners, 4B Technologies has built and is advancing a pipeline of innovative medicines into the clinic to validate their therapeutic potentials. Our aspiration is to become a global leader in developing innovative medicines for neurological diseases. 4B Technologies was registered in Cayman and Hong Kong in 2017 and began its full operation in 2018 with preclinical R&D in Suzhou, and later clinical development in Beijing and Shanghai, China.